Health Monthly Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.

Press releases published on September 9, 2026

9 hours ago

Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

9 hours ago

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

Indeterminate GlobeNewswire

9 hours ago

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

9 hours ago

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Indeterminate GlobeNewswire

10 hours ago

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

10 hours ago

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Indeterminate GlobeNewswire

10 hours ago

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

10 hours ago

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

10 hours ago

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Indeterminate GlobeNewswire

10 hours ago

CRB Names Helga Margrethe Salling Chief Growth Officer

Indeterminate GlobeNewswire

10 hours ago

Kane Biotech to Host Commercial Update Webcast on September 16

Indeterminate GlobeNewswire

10 hours ago

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

10 hours ago

Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer

Indeterminate GlobeNewswire

10 hours ago

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Indeterminate GlobeNewswire

10 hours ago

Fractyl Health to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

Indeterminate GlobeNewswire

10 hours ago

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

10 hours ago

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Indeterminate GlobeNewswire

10 hours ago

Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Indeterminate GlobeNewswire

10 hours ago

Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire